Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transient receptor potential cation channel subfamily V member 3 (Homo sapiens (Human)) | BDBM190589 (US9181219, 2-{[2-(8-methyl-1,2,3,4-tetrahydroquino...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
HYDRA BIOSCIENCES, INC. US Patent | Assay Description To determine whether compounds were selective for TRPV3 inhibition over inhibition of other ion channel types, the human ERG (hERG), NaV1.2, and TRPV... | US Patent US9181219 (2015) BindingDB Entry DOI: 10.7270/Q2DV1HPH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transient receptor potential cation channel subfamily V member 3 (Homo sapiens (Human)) | BDBM190589 (US9181219, 2-{[2-(8-methyl-1,2,3,4-tetrahydroquino...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
HYDRA BIOSCIENCES, INC. US Patent | Assay Description Phase 1: TRPV3 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separatio... | US Patent US9181219 (2015) BindingDB Entry DOI: 10.7270/Q2DV1HPH | |||||||||||
More data for this Ligand-Target Pair |